According to Shen's research [36], serous ovarian cancer is resistant to taxol through the NOD1/RIPK2/NF-κB inflammatory pathway, and NOD1/RIP2 promotes the growth of ovarian cancer by turning on NF-B signaling. This evidence concerns the gene RIPK2 and ovarian serous adenocarcinoma.